Sign in
8-K

Current Report

Oruka Therapeutics, Inc. Filed Acc 0001213900-26-065294

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading ea0293648-8k_oruka.htm…